Neuralstem, Inc. (41)

Browse by Contract Category

Contracts

Leading BioSciences, Inc. Amended and Restated 2013 Employee, Director and Consultant Equity Incentive Plan and Forms of Stock Option Grant Notice, Stock Option Agreement and... (Filed With SEC on December 23, 2020)
Co-Development and Distribution Agreement, by and between Leading BioSciences, Inc. and Newsoara Biopharma Co., Ltd. (as successor-in-interest to Biolead Medical Technology... (Filed With SEC on December 23, 2020)
License Agreement, by and between Leading BioSciences, Inc. and The Regents of the University of California, dated April 1, 2020 (Filed With SEC on December 23, 2020)
Form of Senior Secured Note of Leading BioSciences, Inc (Filed With SEC on December 23, 2020)
Form of LBS Support Agreement, dated as of December 16, 2020, by and between Seneca Biopharma, Inc. and each of the parties named in each agreement therein (Filed With SEC on December 21, 2020)
Agreement and Plan of Merger, dated as of December 16, 2020, by and among Seneca Biopharma, Inc., Leading BioSciences, Inc. and Townsgate Acquisition Sub 1, Inc (Filed With SEC on December 21, 2020)
Executive Employment Agreement, by and between Leading BioSciences, Inc. and JD Finley, dated December 16, 2020 (Filed With SEC on December 23, 2020)
Executive Employment Agreement, by and between Leading BioSciences, Inc. and Thomas Hallam, Ph.D., dated December 16, 2020 (Filed With SEC on December 23, 2020)
Executive Employment Agreement, by and between Leading BioSciences, Inc. and Michael Dawson, M.D., dated December 16, 2020 (Filed With SEC on December 23, 2020)
License Agreement, by and between Leading BioSciences, Inc. and The Regents of the University of California, dated August 19, 2015, as amended on December 20, 2019 (Filed With SEC on December 23, 2020)
Form of Warrant to Purchase Shares of Common Stock of Leading BioSciences, Inc (Filed With SEC on December 23, 2020)
Form of Equity Warrant (Filed With SEC on December 21, 2020)
Registration Rights Agreement, by and between Seneca Biopharma, Inc. and the investor party thereto, dated December 16, 2020 (Filed With SEC on December 21, 2020)
Form of Company Support Agreement, dated as of December 16, 2020, by and between Leading BioSciences, Inc. and each of the parties named in each agreement therein (Filed With SEC on December 21, 2020)
Form of Leak-Out Agreement, by and between Seneca Biopharma, Inc. and the investor party thereto (Filed With SEC on December 21, 2020)
Form of Company Lock-Up Agreement (Filed With SEC on December 21, 2020)
Form of LBS Lock-Up Agreement (Filed With SEC on December 21, 2020)
Securities Purchase Agreement, by and between Leading BioSciences, Inc. and the investor party thereto, dated December 16, 2020 (Filed With SEC on December 21, 2020)
Securities Purchase Agreement, by and among Seneca Biopharma, Inc., Leading BioSciences, Inc. and the investor party thereto, dated December 16, 2020 (Filed With SEC on December 21, 2020)
Form of CVR Agreement (Filed With SEC on December 21, 2020)
Form of Bridge Warrant (Filed With SEC on December 21, 2020)
Form of Securities Purchase Agreement (Filed With SEC on May 27, 2020)
Form of Placement Agent Warrant (Filed With SEC on May 27, 2020)
Employment Agreement with Matthew Kalnik, PhD (Filed With SEC on April 2, 2020)
Employment Agreement with Dane Saglio (Filed With SEC on April 2, 2020)
Amendment to Employment Agreement with Kenneth Carter effective April 1,2020 (Filed With SEC on March 27, 2020)
Inducement Stock Option Plan adopted 2/15/2016 and as amended on 12/12/2018, 9/13/2019, and 3/23/20 (Filed With SEC on March 27, 2020)
Form of Replacement Warrant (Series Q) (Filed With SEC on January 22, 2020)
Form of Replacement Warrant (Series P) (Filed With SEC on January 22, 2020)
Form of Placement Agent Warrant (Filed With SEC on January 22, 2020)
Letter Agreement dated January 17, 2020 (Filed With SEC on January 22, 2020)
Form of Placement Agent Agreement (Filed With SEC on January 22, 2020)
NEURALSTEM, INC. AMENDED AND RESTATED INDUCEMENT AWARD STOCK OPTION PLAN (Filed With SEC on November 14, 2019)
Form of Series O Pre-Funded Warrant (Filed With SEC on July 24, 2019)
Form of Series M and Series N Warrant (Filed With SEC on July 24, 2019)
Form of Underwriting Agreement (Filed With SEC on July 24, 2019)
Form of Restricted Stock Unit from 2019 Equity Incentive Plan (Filed With SEC on June 21, 2019)
Form of Restricted Stock Grant from 2019 Equity Incentive Plan (Filed With SEC on June 21, 2019)
Form of Stock Option Grant from 2019 Equity Incentive Plan (Filed With SEC on June 21, 2019)
Consultant Warrant for Hibiscus BioVentures, LLC issued January 2019 (Filed With SEC on May 14, 2019)
Inducement Stock Option Plan adopted 2/15/2016 and as amended on 12/12/2018 (Filed With SEC on March 22, 2019)